Treatment for eye cancer
A drug for an aggressive form of eye cancer is being fast-tracked to patients by the NHS across England. One patient receiving the treatment described the rollout as “the best early Christmas present I could’ve asked for”. Patients diagnosed with uveal melanoma, which once it has spread to major organs is almost always fatal, can now be offered the first-of-its-kind treatment, tebentafusp, following approval by the National Institute for Health and Care Excellence.